Partial inhibition of class III PI3K VPS-34 ameliorates motor aging and prolongs health span

PLoS Biol. 2023 Jul 11;21(7):e3002165. doi: 10.1371/journal.pbio.3002165. eCollection 2023 Jul.

Abstract

Global increase of life expectancy is rarely accompanied by increased health span, calling for a greater understanding of age-associated behavioral decline. Motor independence is strongly associated with the quality of life of elderly people, yet the regulators for motor aging have not been systematically explored. Here, we designed a fast and efficient genome-wide screening assay in Caenorhabditis elegans and identified 34 consistent genes as potential regulators of motor aging. Among the top hits, we found VPS-34, the class III phosphatidylinositol 3-kinase that phosphorylates phosphatidylinositol (PI) to phosphatidylinositol 3-phosphate (PI(3)P), regulates motor function in aged but not young worms. It primarily functions in aged motor neurons by inhibiting PI(3)P-PI-PI(4)P conversion to reduce neurotransmission at the neuromuscular junction (NMJ). Genetic and pharmacological inhibition of VPS-34 improve neurotransmission and muscle integrity, ameliorating motor aging in both worms and mice. Thus, our genome-wide screening revealed an evolutionarily conserved, actionable target to delay motor aging and prolong health span.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aging
  • Animals
  • Caenorhabditis elegans / genetics
  • Inhibition, Psychological
  • Mice
  • Phosphatidylinositol 3-Kinases*
  • Quality of Life*

Substances

  • phosphatidylinositol 3-phosphate
  • Phosphatidylinositol 3-Kinases

Grants and funding

This work was supported by National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University (Z2021JC006 to YZ), the National Natural Science Foundation of China (82173179 to YZ), Natural Science Foundation of Sichuan Province (2022NSFSC1402 to YZ), the Major International (Regional) Joint Research Project (32020103007 to SG) and the National Key Research and Development Program of China (2022YFA1206001 to SG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.